• Explore /
  • Poster
  • / Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies.

Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies.

Abstract Poster

Authors

null

Daniele Rossini

Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Daniele Rossini , Andrea Sbrana , Francesca Bergamo , Chiara Manai , Daniele Santini , Michele Ghidini , Carlotta Antoniotti , Roberto Moretto , Federica Marmorino , Federica Urbano , Monica Ronzoni , Silvia Noventa , Giovanni Randon , Chiara Carlomagno , Tiziana Pia Latiano , Stefano Sergio Cordio , Cristina Granetto , Chiara Cremolini , Alfredo Falcone , Andrea Antonuzzo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Citation

J Clin Oncol 37, 2019 (suppl; abstr 11591)

DOI

10.1200/JCO.2019.37.15_suppl.11591

Abstract #

11591

Poster Bd #

283

Abstract Disclosures

Similar Posters

First Author: Federica Marmorino

First Author: Marco Maria Germani

First Author: Douglas W. Blayney

First Author: Angela Damato